HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.

AIM: To determine the glycosylated haemoglobin (HbA(1c)) cut-points for diabetes and impaired fasting glucose (IFG) among Asian Indians. METHODS: Participants (n=525) were a random sample selected from the India Health Study. Based on history and fasting plasma glucose (FPG), participants were clas...

Full description

Bibliographic Details
Main Authors: Nair, M, Prabhakaran, D, Narayan, K, Sinha, R, Lakshmy, R, Devasenapathy, N, Daniel, C, Gupta, R, George, P, Mathew, A, Tandon, N, Reddy, K
Format: Journal article
Language:English
Published: 2011
_version_ 1826303812687626240
author Nair, M
Prabhakaran, D
Narayan, K
Sinha, R
Lakshmy, R
Devasenapathy, N
Daniel, C
Gupta, R
George, P
Mathew, A
Tandon, N
Reddy, K
author_facet Nair, M
Prabhakaran, D
Narayan, K
Sinha, R
Lakshmy, R
Devasenapathy, N
Daniel, C
Gupta, R
George, P
Mathew, A
Tandon, N
Reddy, K
author_sort Nair, M
collection OXFORD
description AIM: To determine the glycosylated haemoglobin (HbA(1c)) cut-points for diabetes and impaired fasting glucose (IFG) among Asian Indians. METHODS: Participants (n=525) were a random sample selected from the India Health Study. Based on history and fasting plasma glucose (FPG), participants were classified into known diabetes, newly diagnosed diabetes (NDD), impaired fasting glucose (IFG) [ADA and WHO criteria] or normal fasting glucose (NFG). Receiver Operating Characteristic curves were used to identify the optimum sensitivity and specificity for defining HbA(1c) cut-points for NDD and IFG against the FPG criteria. RESULTS: There were 64 participants with a known history of diabetes. Of the remaining 461, IFG was present in 44.7% (ADA) and 18.2% (WHO), and 10.4% were NDD. Mean HbA(1c) were 5.4 (±0.04)% for NFG; 5.7 (±0.06)% among IFG-ADA, 5.8 (±0.09)% among IFG-WHO; 7.5 (±0.33)% for NDD and 8.4 (±0.32)% for known diabetes. Optimal HbA(1c) cut-point for NDD was 5.8% (sensitivity=75%, specificity=75.5%, AUC=0.819). Cut-point for IFG (ADA) was 5.5% (sensitivity=59.7%, specificity=59.9%, AUC=0.628) and for IFG (WHO) was 5.6% (sensitivity=60.7%, specificity=65.1%, AUC=0.671). CONCLUSION: In this study population from north and south regions of India, the HbA(1c) cut-point that defines NDD (≥5.8%) was much lower than that proposed by an international expert committee and the American Diabetes Association (≥6.5%). A cut-point of ≥5.5% or ≥5.6% defined IFG, and was slightly lower than the ≥5.7% for high risk proposed, but accuracy was less than 70%.
first_indexed 2024-03-07T06:08:23Z
format Journal article
id oxford-uuid:ee9e78ef-c499-4e33-9763-a1f838a491c2
institution University of Oxford
language English
last_indexed 2024-03-07T06:08:23Z
publishDate 2011
record_format dspace
spelling oxford-uuid:ee9e78ef-c499-4e33-9763-a1f838a491c22022-03-27T11:34:11ZHbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ee9e78ef-c499-4e33-9763-a1f838a491c2EnglishSymplectic Elements at Oxford2011Nair, MPrabhakaran, DNarayan, KSinha, RLakshmy, RDevasenapathy, NDaniel, CGupta, RGeorge, PMathew, ATandon, NReddy, K AIM: To determine the glycosylated haemoglobin (HbA(1c)) cut-points for diabetes and impaired fasting glucose (IFG) among Asian Indians. METHODS: Participants (n=525) were a random sample selected from the India Health Study. Based on history and fasting plasma glucose (FPG), participants were classified into known diabetes, newly diagnosed diabetes (NDD), impaired fasting glucose (IFG) [ADA and WHO criteria] or normal fasting glucose (NFG). Receiver Operating Characteristic curves were used to identify the optimum sensitivity and specificity for defining HbA(1c) cut-points for NDD and IFG against the FPG criteria. RESULTS: There were 64 participants with a known history of diabetes. Of the remaining 461, IFG was present in 44.7% (ADA) and 18.2% (WHO), and 10.4% were NDD. Mean HbA(1c) were 5.4 (±0.04)% for NFG; 5.7 (±0.06)% among IFG-ADA, 5.8 (±0.09)% among IFG-WHO; 7.5 (±0.33)% for NDD and 8.4 (±0.32)% for known diabetes. Optimal HbA(1c) cut-point for NDD was 5.8% (sensitivity=75%, specificity=75.5%, AUC=0.819). Cut-point for IFG (ADA) was 5.5% (sensitivity=59.7%, specificity=59.9%, AUC=0.628) and for IFG (WHO) was 5.6% (sensitivity=60.7%, specificity=65.1%, AUC=0.671). CONCLUSION: In this study population from north and south regions of India, the HbA(1c) cut-point that defines NDD (≥5.8%) was much lower than that proposed by an international expert committee and the American Diabetes Association (≥6.5%). A cut-point of ≥5.5% or ≥5.6% defined IFG, and was slightly lower than the ≥5.7% for high risk proposed, but accuracy was less than 70%.
spellingShingle Nair, M
Prabhakaran, D
Narayan, K
Sinha, R
Lakshmy, R
Devasenapathy, N
Daniel, C
Gupta, R
George, P
Mathew, A
Tandon, N
Reddy, K
HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title_full HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title_fullStr HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title_full_unstemmed HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title_short HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
title_sort hba 1c values for defining diabetes and impaired fasting glucose in asian indians
work_keys_str_mv AT nairm hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT prabhakarand hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT narayank hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT sinhar hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT lakshmyr hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT devasenapathyn hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT danielc hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT guptar hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT georgep hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT mathewa hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT tandonn hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians
AT reddyk hba1cvaluesfordefiningdiabetesandimpairedfastingglucoseinasianindians